Topics

Xontogeny LLC Company Profile

05:17 EDT 17th September 2019 | BioPortfolio

Xontogeny was founded by industry veteran Chris Garabedian and launched with a $25M Series A round in May 2017. The company, based in Boston, MA, seeks to support and accelerate the development of life science technologies from early development through clinical proof-of-concept. Xontogeny provides entrepreneurs with the leadership, strategic guidance and operational support necessary to increase the probability of success in early drug and technology development. Through a differentiated approach, the Xontogeny team partners with the founding scientists and entrepreneurs of new ventures to support their vision while allowing a more efficient development model to benefit company founders and early equity holders. For more information, please visit www.xontogeny.com or contact Xontogeny by emailing info@xontogeny.com.


News Articles [3 Associated News Articles listed on BioPortfolio]

Landos Biopharma completes £49.7m series B financing

The financing was co-led by RTW Investments and Perceptive Advisors (Perceptive Xontogeny Venture Fund and Perceptive Life Sciences Fund), and joined by additional new investors, including Osage Unive...

LaVoieHealthScience Honored with Bell Ringer Awards in Both Investor Relations and Executive Thought Leadership Categories

LaVoieHealthScience wins two Bell Ringer Awards from the PR Club of New England BOSTON (PRWEB) June 07, 2019 LaVoieHealthScience (LHS), an integrated public and investor relations agency focused on a...

Landos Biopharma Completes $60 Million Series B Financing

- RTW Investments joins existing investor Perceptive Advisors in leading financing with a strong syndicate - - Proceeds will support two global Phase 2 studies of lead product BT-11 for Ulcerative ...

Drugs and Medications [0 Results]

None

PubMed Articles [0 Results]

None

Clinical Trials [0 Results]

None

Companies [1 Associated Companies listed on BioPortfolio]

Xontogeny LLC

Xontogeny was founded by industry veteran Chris Garabedian and launched with a $25M Series A round in May 2017. The company, based in Boston, MA, seeks to support and accelerate t...

More Information about "Xontogeny LLC" on BioPortfolio

We have published hundreds of Xontogeny LLC news stories on BioPortfolio along with dozens of Xontogeny LLC Clinical Trials and PubMed Articles about Xontogeny LLC for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Xontogeny LLC Companies in our database. You can also find out about relevant Xontogeny LLC Drugs and Medications on this site too.

Quick Search

Corporate Database Quicklinks



Searches Linking to this Company Record